查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190545

牙科生物材料市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Dental Biomaterials Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2021 年牙科生物材料市场价值约为 64.6475 亿美元，预计到 2027 年将达到 94.8713 亿美元，在 2022-2027 年的预测期内以 6.77% 的复合年增长率增长。我来了。

COVID-19 大流行对市场的影响很大，包括牙科护理在内的一些选择性手术在大流行期间暂停或推迟。 2020 年 3 月，美国牙科协会 (ADA) 将所有选择性牙科护理推迟到 2020 年 4 月 6 日，以防止患者给医院急诊科带来过多负担，从而推迟仅提供紧急牙科服务。建议提供 该公告于 2020 年 4 月 1 日更新，ADA 建议由于 COVID-19 病例增加，除紧急和急救外，诊所关闭至 4 月 30 日。 结果，获得牙科保健的机会大大减少。 而根据英国牙科协会公布的数据，2020年7月，英国2053名牙医中只有36%的人有条件恢復牙科执业。 在大流行的早期阶段，牙科服务和治疗的延迟减少了对牙科生物材料的需求，对市场增长产生了负面影响。 然而，随着 COVID-19 的严重程度和感染率下降，随着全球选择性牙科护理的恢復，市场正在获得吸引力。

此外，推动市场增长的主要因素包括牙科疾病负担的增加、牙科旅游的扩张、种植牙普及率的提高以及新兴国家可支配收入的增加。

牙科疾病负担的增加和牙科旅游的增加是推动市场增长的主要因素。 牙周病、蛀牙、口腔癌、口臭和龋齿等牙科疾病负担的增加是市场增长的推动力。 例如，根据世界卫生组织（WHO）2020年3月的最新信息，口腔疾病估计影响全球约35亿人，其中严重的牙周（牙龈）疾病尤为常见。。 还有一篇标题为“牙科旅游 2021”的文章。 2021 年 12 月在 Dentaly.org 上发表的“在国外获得更便宜的牙科植入物和贴面”指出，牙科植入物旅游是一项受成本节约□□推动的不断增长的业务。 预计这些因素将在未来几年推动牙科生物材料的需求，从而增加患者对牙科手术的采用。

然而，监管问题和治疗成本是限制市场增长的因素之一。

牙科生物材料的市场趋势

金属生物材料板块有望在预测期内快速增长

按类型划分，金属生物材料预计将显着增长。 金属生物材料是牙科中使用的一类主要材料。 这是由于与这些材料相关的高强度和其他机械性能。 这些生物材料由于钛、镓和硅等的承重和抗疲劳特性而被广泛用于製造外科植入物。

在2021年11月发表的一篇题为“社论”的文章“Metallic Biomaterials for Medical Applications”中，与其他金属植入材料相比，钛合金具有优越的生物相容性、耐腐蚀性和比强度。因此，它被广泛用作牙科材料和植入材料。 此外，根据 2020 年 8 月发表的论文“Review of Metallic Biomaterials in Dental Applications”，Ti-Ga-Si 将 Ti-Ga 合金的优点与 Si 相结合，为患者带来了美观的效果。据信可以增强骨整合，并具有最小的医疗并发症的可能性。

此类研究将对该细分市场的增长产生积极影响，因为它证明了金属生物材料的有效性，并有望创造对金属植入物的巨大需求。

北美有望在预测期内实现高增长

在北美地区，美国有望实现显着增长。 政府机构支持的产品发布增加、牙科疾病负担增加以及老年人口不断增加正在推动美国对牙科生物材料的需求。

例如，根据美国牙科协会的数据，到 2020 年，将有超过 500 万年龄在 65 至 74 岁之间的美国人完全没有牙齿，近 300 万将患有无牙颌。 另一方面，掉牙主要是老年人的问题。 由于 91% 的 20-64 岁成年人有蛀牙，其中 27% 未接受治疗。 此外，因蛀牙而导致牙齿脱落的案例也很多。 因此，预计这些因素将增加美国进行的牙科手术总数，从而增加国内对牙科生物材料的需求。

此外，一些市场参与者也参与实施战略计划，从而推动市场增长。 例如，2020 年 1 月，位于大波士顿地区的牙科研究和製造公司 Pulpdent Corporation 推出了 ACTIVA Presto 牙科材料。 这种新型白色牙科填充材料模仿了天然牙齿的特性。 此外，2021 年 4 月，高科技牙科材料和设备的开发商和製造商 Ultradent Products 将收购墨西哥牙科产品蓝筹分销商 Vamasa SA de CV 的多数股权。底部。

因此，考虑到上述因素，预计该市场在预测期内将出现显着增长。

牙科生物材料市场竞争分析

由于国内外参与者的存在，牙科生物材料市场竞争激烈。 大部分市场份额被全球玩家占据，而中小企业则在新技术的帮助下展开激烈的竞争。 未来，随着新进入者开发创新产品，市场份额有望在国际和小型企业之间实现多元化。 主要参与者包括 Straumann Holding AG、Dentsply Sirona Inc.、3M Company、ZimVie Inc. 和 Botiss Biomaterials GmbH。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查结果
  • 调查假设
  • 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 牙科疾病负担的增加和牙科旅游的扩大
    • 提高种植牙的渗透率
    • 新兴国家的可支配收入增加
  • 市场製约因素
    • 监管问题
    • 治疗费用
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按类型
    • 金属生物材料
      • 钛
      • 不銹钢
      • 铬合金
      • 其他金属生物材料
    • 陶瓷生物材料
    • 高分子生物材料
    • 天然生物材料
    • 其他类型
  • 通过使用
    • 牙齿矫正
    • 假牙
    • 其他用途
  • 最终用户
    • 医院和诊所
    • 学术和研究机构
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东和非洲地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • GC Corporation
    • Victrex PLC
    • Medtronic PLC
    • Straumann Holding AG
    • ZimVie Inc.
    • Dentsply Sirona Inc.
    • Royal DSM
    • Danaher Corporation
    • 3M Company
    • Bay Materials
    • Vannini Dental Industry SRL
    • Kyocera Corporation
    • Botiss Biomaterials GmbH

第7章 市场机会今后动向

简介目录
Product Code: 67115

The dental biomaterials market was valued at about USD 6,464.75 million in 2021, and it is expected to reach USD 9,487.13 million by 2027, recording a CAGR of 6.77% over the forecast period 2022-2027.

The impact of the COVID-19 pandemic on the market was significant as several elective procedures, including dental treatments, were halted or postponed during the pandemic. In March 2020, the American Dental Association (ADA) recommended postponing all elective dental procedures until April 6, 2020, and providing emergency-only dental services to keep patients from burdening hospital emergency departments. This recommendation was updated on April 1, 2020, when the ADA advised offices to remain closed except for urgent and emergency procedures until April 30, owing to the rise of COVID-19 cases. As a result, access to dental care substantially decreased. Also, as per data published by the British Dental Association, in July 2020, out of 2,053 dentists, only 36% were ready to resume dental practices in United Kingdom. ​During the initial phase of the pandemic, dental services and treatments were delayed, which resulted in decreased demand for dental biomaterials and affected market growth adversely. However, the market is gaining traction as elective dental procedures have resumed worldwide owing to the declining severity and infections of COVID-19.

Further, the major factors fueling the market growth include the rising burden of dental disorders, growing dental tourism, growing penetration of dental implants, and increasing disposable income across developing countries.

The rising burden of dental disorders and growing dental tourism are major factors driving the market growth. The growing burden of dental diseases such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, among other diseases, is driving the market growth. For instance, as per a March 2020 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people globally, especially severe periodontal (gum) disease. Also, an article titled "Dental Tourism 2021: Get Cheaper Dental Implants and Veneers Abroad," published in Dentaly.org in December 2021, stated that dental implant tourism is a growing business attributed to cost savings. Such factors are thereby increasing the adoption of dental procedures among patients and are expected to drive the demand for dental biomaterials over the coming years.

Nevertheless, regulatory issues and the cost of procedures are some of the factors restraining the market growth.

Dental Biomaterials Market Trends

Metallic Biomaterials Segment Expected to Witness High Growth over the Forecast Period

By type, metallic biomaterials are expected to witness significant growth. Metallic biomaterials are a central class of materials for use in dental treatments. This can be attributed to the high strength and other mechanical properties associated with these materials. These biomaterials are extensively used to fabricate surgical implants owing to load-bearing characteristics and fatigue properties, such as titanium, gallium, and silicon.

​As per an article published in November 2021, titled "Editorial: Metallic Biomaterials for Medical Applications," titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and specific strength compared with other metallic implant materials. In addition, as per an article titled, "Review of Metallic Biomaterials in Dental Applications," published in August 2020, Ti-Ga-Si is considered to combine the advantages of the Ti-Ga alloy along with Si, which enhances the osseointegration with aesthetically pleasing outcomes for patients and minimal likelihood of medical complications.

Such studies indicate the efficacy of metallic biomaterials and are expected to generate significant demand for metallic implants, thus positively impacting the segment's growth.​

North America Expected to Witness High Growth over the Forecast Period

Within North America, United States is expected to observe significant growth. With the increase in product launches supported by government authorities, the rising burden of dental diseases and the increasing geriatric population are bolstering the demand for dental biomaterials in United States.​

For instance, as per the American Dental Association, in 2020, more than 5 million US seniors aged 65 to 74 had complete tooth loss, with nearly 3 million suffering from edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly. This is because 91% of adults aged 20 to 64 have dental caries, with a staggering 27% going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. Thus, such factors are anticipated to boost the total dental procedures performed across United States, thereby boosting the demand for dental biomaterials within the country.

​Furthermore, several market players are also engaged in implementing strategic initiatives, thereby propelling market growth. For instance, in January 2020, Pulpdent Corporation, a dental research and manufacturing company based in the Greater Boston area, launched its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. ​Moreover, in April 2021, Ultradent Products Inc., a developer and manufacturer of high-tech dental materials and equipment, purchased majority ownership in Vamasa SA de CV, a premier distributor of dental products in Mexico.

Thus, in view of the abovementioned factors, the market is expected to witness significant growth in the region over the forecast period.

Dental Biomaterials Market Competitive Analysis

The dental biomaterials market is moderately competitive, with the presence of local and international players in the market. The major share of the market has been grabbed by global players, whereas small to mid-sized companies are posing intense competition with the help of novel technologies. In the future, it is expected that the market share will be distributed among international players and small players as well due to the focus of new entrants to come up with innovative products. Some of the major players in the market are Straumann Holding AG, Dentsply Sirona Inc., 3M Company, ZimVie Inc., and Botiss Biomaterials GmbH.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Dental Disorders and Growing Dental Tourism
    • 4.2.2 Increasing Penetration of Dental Implants
    • 4.2.3 Increase in Disposable Incomes across Developing Countries
  • 4.3 Market Restraints
    • 4.3.1 Regulatory Isssues
    • 4.3.2 Cost of the Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Type
    • 5.1.1 Metallic Biomaterials
      • 5.1.1.1 Titanium
      • 5.1.1.2 Stainless Steel
      • 5.1.1.3 Chromium Alloys
      • 5.1.1.4 Other Metallic Biomaterials
    • 5.1.2 Ceramic Biomaterials
    • 5.1.3 Polymeric Biomaterials
    • 5.1.4 Natural Biomaterials
    • 5.1.5 Other Types
  • 5.2 By Application
    • 5.2.1 Orthodontics
    • 5.2.2 Prosthodontics
    • 5.2.3 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Academies and Research Institutes
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GC Corporation
    • 6.1.2 Victrex PLC
    • 6.1.3 Medtronic PLC
    • 6.1.4 Straumann Holding AG
    • 6.1.5 ZimVie Inc.
    • 6.1.6 Dentsply Sirona Inc.
    • 6.1.7 Royal DSM
    • 6.1.8 Danaher Corporation
    • 6.1.9 3M Company
    • 6.1.10 Bay Materials
    • 6.1.11 Vannini Dental Industry SRL
    • 6.1.12 Kyocera Corporation
    • 6.1.13 Botiss Biomaterials GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS